EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 344 filers reported holding EXELIXIS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $972,325 | +14.3% | 44,500 | 0.0% | 0.06% | +19.1% |
| Q2 2023 | $850,395 | -1.5% | 44,500 | 0.0% | 0.05% | -7.8% |
| Q1 2023 | $863,745 | +21.0% | 44,500 | 0.0% | 0.05% | +15.9% |
| Q4 2022 | $713,780 | +2.3% | 44,500 | 0.0% | 0.04% | -8.3% |
| Q3 2022 | $698,000 | -24.6% | 44,500 | 0.0% | 0.05% | -21.3% |
| Q2 2022 | $926,000 | -8.2% | 44,500 | 0.0% | 0.06% | +8.9% |
| Q1 2022 | $1,009,000 | +24.1% | 44,500 | 0.0% | 0.06% | +36.6% |
| Q4 2021 | $813,000 | -13.6% | 44,500 | 0.0% | 0.04% | -21.2% |
| Q3 2021 | $941,000 | +49.6% | 44,500 | +29.0% | 0.05% | +48.6% |
| Q2 2021 | $629,000 | -19.3% | 34,500 | 0.0% | 0.04% | -25.5% |
| Q1 2021 | $779,000 | +12.6% | 34,500 | 0.0% | 0.05% | +6.8% |
| Q4 2020 | $692,000 | -18.0% | 34,500 | 0.0% | 0.04% | -29.0% |
| Q3 2020 | $844,000 | +3.1% | 34,500 | 0.0% | 0.06% | -4.6% |
| Q2 2020 | $819,000 | +37.9% | 34,500 | 0.0% | 0.06% | +14.0% |
| Q1 2020 | $594,000 | -2.3% | 34,500 | 0.0% | 0.06% | +29.5% |
| Q4 2019 | $608,000 | -0.3% | 34,500 | 0.0% | 0.04% | -8.3% |
| Q3 2019 | $610,000 | -17.2% | 34,500 | 0.0% | 0.05% | -17.2% |
| Q2 2019 | $737,000 | -10.2% | 34,500 | 0.0% | 0.06% | -12.1% |
| Q1 2019 | $821,000 | +20.9% | 34,500 | 0.0% | 0.07% | +3.1% |
| Q4 2018 | $679,000 | +11.1% | 34,500 | 0.0% | 0.06% | +30.6% |
| Q3 2018 | $611,000 | -17.7% | 34,500 | 0.0% | 0.05% | -23.4% |
| Q2 2018 | $742,000 | -2.9% | 34,500 | 0.0% | 0.06% | -7.2% |
| Q1 2018 | $764,000 | -27.2% | 34,500 | 0.0% | 0.07% | -26.6% |
| Q4 2017 | $1,049,000 | – | 34,500 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,966,038 | $282,918,000 | 60.81% |
| NEXTHERA CAPITAL LP | 1,735,030 | $30,745,000 | 5.89% |
| GREAT POINT PARTNERS LLC | 2,075,000 | $36,769,000 | 5.73% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 704,534 | $9,574,000 | 4.55% |
| Matrix Capital Management Company, LP | 10,000,000 | $177,200,000 | 4.38% |
| Consonance Capital Management LP | 3,879,050 | $68,737,000 | 3.70% |
| Rhenman & Partners Asset Management AB | 1,261,414 | $22,352,000 | 2.24% |
| BB BIOTECH AG | 2,785,000 | $49,350,000 | 1.31% |
| CAPITAL MANAGEMENT CORP /VA | 285,575 | $5,060,000 | 1.29% |
| TEALWOOD ASSET MANAGEMENT INC | 155,376 | $2,753,000 | 1.03% |